Bioxyne Limited (ASX: BXN) says it has entered the German cannabis market through its subsidiary Breathe Life Sciences (BLS) in a multi-million-dollar deal. BLS has executed a manufacture and supply agreement with German firms Farmakem d.o.o. as Buyer and Adrex Pharmaceuticals GmbH, an importer, manufacturer, and distributor of cannabis in Germany. Farmakem and Adrex have … Continue reading Australia’s Bioxyne Inks German Medical Cannabis Supply Deal